An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 267 - 273 of 912
Discrimination may lead to unhealthy gut-brain changes
People who reported high levels of discrimination in their daily lives had increased brain activity in response to unhealthy food triggers.
App aids early screening for autism
A tablet-based app that records toddlers’ responses to videos holds promise for improved early detection and intervention.
How SARS-CoV-2 contributes to heart attacks and strokes
The virus that causes COVID-19 can infect coronary arteries and increase inflammation in atherosclerotic plaques.
Research in Context
Obesity and metabolic health
Losing weight and reversing obesity might seem straightforward: eat fewer calories than you burn. But that’s not as easy as it sounds. This special feature explores the many factors that affect the body’s metabolism.
Dysfunctional exosomes involved in chronic inflammation in diabetic wounds
Tiny signaling particles called exosomes isolated from the chronic wounds of people with diabetes were dysfunctional and promoted inflammation.
Immune and hormonal features of Long COVID
Immune and hormonal differences between people with Long COVID and those without shed light on possible causes of Long COVID.
Scientists find common brain network for substance use disorders
Researchers identified a common brain network that’s linked to addiction across multiple substances.